Lightnews — Scholar-powered news

Reposted by Ankur Pandya

Center for Health Decision Science (CHDS) @ctrdecisionscience.bsky.social · 6d

CHDS affiliate Karen Smith co-authored a cost-effectiveness analysis of intensive blood pressure targets in settings with blood pressure measurement error, with colleagues including CHDS' Thomas Gaziano, Nicolas Menzies, and Ankur Pandya (@ankurfactorial.bsky.social).

📝Read more: shorturl.at/4Kekr

1 2

Reposted by Ankur Pandya

Adrianna McIntyre @adrianna.bsky.social · 10d

It’s that time of year again: The information session for Harvard’s PhD in Health Policy will be held a month from today, on Tuesday, October 28.

Register here (recording will be available for those who can’t make it): harvard.zoom.us/meeting/regi...

3 8

Reposted by Ankur Pandya

Adrianna McIntyre @adrianna.bsky.social · 14d

A new paper led by Harvard Health Policy PhD student Ye Shen finds that, in the current policy environment, more than six in ten kids will have been enrolled in Medicaid for some period of time by their 18th birthday; the program is absolutley critical for children.

jamanetwork.com/journals/jam...

4 38 61

Reposted by Ankur Pandya

Adam Raymakers @araymakers.bsky.social · 15d

Excited to share new research led by Jessica Harvey exploring the budget impact of gene therapies for sickle cell disease, with a focus on Medicaid programs.

Co-As: @ankurfactorial.bsky.social, @leah-rand.bsky.social, @akesselheim.bsky.social, & George Goshua.

🔗: link.springer.com/article/10.1...

Modeling the Budgetary Impacts of Sickle Cell Disease Gene Therapies on State Medicaid Programs - Journal of General Internal Medicine

Journal of General Internal Medicine -

link.springer.com

2 2 6

Ankur Pandya @ankurfactorial.bsky.social · 16d

Tomato season ya bish (my in-laws canning, not us!)

4

Ankur Pandya @ankurfactorial.bsky.social · 19d

Dr Seuss, MD not as good with book sales

1 2 12

Reposted by Ankur Pandya

Emily Moin @emilymoin.com · 20d

Interesting, feasible, impactful, choose 2

1 1 8

Reposted by Ankur Pandya

Peter Neumann @peterneumann11.bsky.social · 25d

In this just published paper in Value in Health led by Feng Xie and colleagues, we reviewed the published cost-effectiveness evidence for the 15 drugs selected for IPAY 2027 Medicare negotiations.

@djvanness.bsky.social @ankurfactorial.bsky.social
www.valueinhealthjournal.com/article/S109...

Cost Effectiveness of the 15 Drugs Selected for IPAY 2027 CMS Drug Price Negotiation

To analyze published cost-effectiveness analyses (CEAs) for the 15 drugs selected for the Initial Price Applicability Year 2027 by the Centers for Medicare and Medicaid Services (CMS).

www.valueinhealthjournal.com

1 2 1

Ankur Pandya @ankurfactorial.bsky.social · Sep 7

Short arms 🤣

1

Ankur Pandya @ankurfactorial.bsky.social · Sep 7

Maye looks great, will take a million hits this year tho

1 1

Ankur Pandya @ankurfactorial.bsky.social · Sep 6

To my haters:

Mina Kimes @minakimes.bsky.social · Sep 6

MATH COMES FOR EVERYONE

Sheil Kapadia @sheilkapadia.bsky.social · Sep 6

Chiefs last year in games decided by 7 points or fewer: 10-0.

That was the best record in such games for any team in the last 25 years.

0-1 in 2025.